Initial Testing of Lenalidomide by the Pediatric Preclinical Testing Program

BACKGROUND: Lenalidomide, a novel immunomodulatory agent, is reported to modulate stem cell differentiation, and have direct antiproliferative activity as well as inhibit inflammation and hyperalgesia. On the basis of this varied pharmacological profile, lenalidomide is under investigation as a trea...

Fuld beskrivelse

Na minha lista:

Bibliografiske detaljer
Udgivet i:	Pediatr Blood Cancer
Main Authors:	Reynolds, C. Patrick, Kang, Min H., Keir, Stephen T., Gorlick, Richard, Kolb, E. Anders, Lock, Richard, Maris, John M., Carol, Hernan, Morton, Christopher L., Billups, Catherine A., Smith, Malcolm A., Houghton, Peter J.
Format:	Artigo
Sprog:	Inglês
Udgivet:	2011
Fag:	Article
Online adgang:	https://ncbi.nlm.nih.gov/pmc/articles/PMC4505747/ https://ncbi.nlm.nih.gov/pubmed/21360651 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.22877
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!

Initial Testing of Lenalidomide by the Pediatric Preclinical Testing Program

Lignende værker